Alana Hippensteele is lead editor at Pharmacy Times®, Contemporary Clinic, and Pharmacy Times Oncology Edition®. She has a master's in Critical Theory and Creative Research from Pacific Northwest College of Art and a bachelor's degree in English and Art History. She has worked as an English instructor at Temple University and held editorial positions at American Cleaning & Hygiene and Tin House.
Preliminary Results of Ciltacabtagene Autoleucel in Treating Relapsed/Refractory Multiple Myeloma
December 10th 2020Data from a preliminary phase 1b/2 study demonstrated a single low-dose infusion of ciltacabtagene autoleucel resulted in early, deep, and durable responses in heavily pretreated patients with multiple myeloma.
Read More
Impact of the COVID-19 Pandemic on Breast Cancer Treatment, Management Across the Country
December 9th 2020There were significant modifications in breast cancer treatment due to the coronavirus disease 2019 pandemic, such as high rates of NET chemotherapy, genomic assay testing on core biopsies, and delays in planned surgeries.
Read More
The Importance of Conducting PrEP Counseling With a Sex Positive Approach
December 8th 2020At the virtual 2020 ASHP Midyear Clinical Meeting and Exhibition, Elyse Tung, PharmD, BCACP, discussed key counseling points for pharmacists to address with patients when prescribing and managing PrEP.
Read More
NCPA, NACDS Applaud HHS for Including Pharmacies in the COVID-19 Vaccine Program
November 20th 2020The NCPA and NACDS both applauded the HHS announcement regarding the partnerships with national and regional chain pharmacies and independent pharmacies to maximize access to COVID-19 vaccines.
Read More
Study: Patients With COVID-19 Should Continue Treatment With ACE Inhibitors, ARBs
November 19th 2020Results of a recent study confirmed that patients already taking angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) should not discontinue taking them due to COVID-19 infection.
Read More
COVID-19 and Atrial Arrhythmias May Increase Risk of Major Adverse Cardiac Events, Death
November 18th 2020For patients with COVID-19, the combination of the disease and preexisting atrial arrhythmias may create a pathologic synergy that significantly increases the risk for major adverse cardiac events and death.
Read More
Study: Black Women More Likely to Experience Delays in Breast Cancer Treatment
November 5th 2020Black women experience longer waiting periods before treatment is initiated than White women following a breast cancer diagnosis, as well as a prolonged treatment duration compared with White women.
Read More